J 2014

Very rare diseases in oncology

SZTURZ, Petr

Basic information

Original name

Very rare diseases in oncology

Authors

SZTURZ, Petr (203 Czech Republic, guarantor, belonging to the institution)

Edition

Medical oncology, Totowa, HUMANA PRESS INC, 2014, 1357-0560

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.634

RIV identification code

RIV/00216224:14110/14:00075887

Organization unit

Faculty of Medicine

UT WoS

000339002800023

Keywords in English

oncology diseases

Tags

Tags

International impact, Reviewed
Změněno: 17/9/2014 15:50, Soňa Böhmová

Abstract

V originále

Chen et al. [1] presented an important study on potential molecular prognostic predictors of recurrence in sacral chordoma. I wish to draw the readers’ attention to epidemiological and related socioeconomic and ethical issues of such a rare diagnosis. Various definitions for sporadic diseases have been proposed based on different cutoff incidence or prevalence rates. Some of these definitions delineate a substantial portion of the overall population disease burden. The apparent complexity of the group of rare diseases implies further explorations including the most uncommon entities.

Links

MUNI/A/0723/2012, interní kód MU
Name: Nové klinické a diagnostické přístupy u hematogických malignit (Acronym: NoKliDiPřiHeMa)
Investor: Masaryk University, Category A